Stock ACRV ACRIVON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Acrivon Therapeutics, Inc.

Equities

ACRV

US0048901096

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
7.25 USD -1.23% Intraday chart for Acrivon Therapeutics, Inc. -6.09% +47.36%
05-14 Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 North American Morning Briefing : More Earnings -2- DJ

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Acrivon Therapeutics, Inc. Appoints Santhosh Palani to its Board of Directors
CI
Acrivon Therapeutics, Inc. Appoints Ivana Magovcevic-Liebisch to its Board of Directors
CI
Acrivon Therapeutics Names Jean-Marie Cuillerot as Chief Medical Officer
MT
Acrivon Therapeutics, Inc. Announces Management Changes
CI
Acrivon Therapeutics Announces the Appointment of Adam Levy as Senior Vice President and Head, Investor Relations and Corporate Affairs
CI
Acrivon Therapeutics, Inc. Appoints Charles Baum as Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACRV Stock
  4. News Acrivon Therapeutics, Inc.
  5. Insiders